CX-6258 hydrochloride hydrate: A potential non-nucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus

Human norovirus (HuNoV), a primary cause of non-bacterial gastroenteritis, currently lacks approved treatment. RdRp is vital for virus replication, making it an attractive target for therapeutic intervention. By application of structure -based virtual screening procedure, we present CX-6258 hydrochloride hydrate as a potent RdRp nonnucleoside inhibitor, effectively inhibiting HuNoV RdRp activity with an IC 50 of 3.61 mu M. Importantly, this compound inhibits viral replication in cell culture, with an EC 50 of 0.88 mu M. In vitro binding assay validate that CX-6258 hydrochloride hydrate binds to RdRp through interaction with the " B -site " binding pocket. Interestingly, CX-6258-contacting residues such as R392, Q439, and Q414 are highly conserved among major norovirus GI and GII variants, suggesting that it may be a general inhibitor of norovirus RdRp. Given that CX-6258 hydrochloride hydrate is already utilized as an orally efficacious pan-Pim kinase inhibitor, it may serve as a potential lead compound in the effort to control HuNoV infections.